Current treatment methods fail to produce survival in as many as 25-30% of newborn infants with "early onset" bacterial sepsis (23) . Diminished host resistance, due to incomplete development of the neutrophil system (3, 4, 17, 26) and in many infants, also due to diminished opsonizing capacity (1, 16) certainly contributes to their refractoriness to treatment. Because of the neonate's diminished host resistance, investigators have predicted that new adjunctive treatment modalities, directed at supplementing host defense, must be developed if further diminution in the mortality rate from sepsis neonatorum is to be made (18) . One such potential modality is the administration of antibody. We have previously shown that when type-specific IgM antibody, prepared from hybridoma cell lines, was administered to neonatal animals together with bacteria, the mortality rate decreased from 90% to zero (5) . In addition, our previous work demonstrated an important interaction between antibody and the neutrophil system: antibody facilitates rapid release of neutrophils from storage and enhances the efficiency of neutrophil migration toward the site of infection (5) . Therefore, antibody may require an intact neutrophil supply for its protective action. In the present report, we demonstrate that this antibody did protect neonates who had established GBS infection; however, protection did not occur when the antibody was administered after the neutrophil storage pool had been depleted.
MATERIALS AND METHODS
Preparation of bacteria. Type I11 group B streptococci, identified by the precipitin method of Lancefield (14), were isolated from the blood of a human neonate with severe early onset disease. This was the same strain of type 111 GBS used in several of our previous reports (3, 5, 7). The organisms were grown to logarithmic phase at 37" C in Todd-Hewitt broth, then washed three times with PBS and aliquots were frozen at -70" C. Prior to inoculation into rats, the aliquots were thawed and grown to logarithmic phase in fresh Todd-Hewitt broth. Bacteria were then sedimented by centrifugation and the concentrated organisms were washed three times in PBS. The suspensions were diluted in PBS to an optical density of 0.9 at 620 nm (Spectronic 20, Bausch and Lomb, Inc., Rochester, NY) producing a final concentration of 1 X lo9 colony-forming units/ml.
Hybridoma antibody preparation. The details of production and characterization of monoclonal antibodies have been described elsewhere (19) . In brief, BALB/c mice were multiply immunized with live type I11 GBS. Animals were sacrificed and their spleens were removed. Spleen cells were then fused with nonsecreting SP 210 cells using polyethylene glycol. Following incubation in selective media containing hypoxanthine, aminopterin, and thymidine, antibody-secreting cells were detected using an enzyme-linked immunoassay (20) . Cells were cloned by limiting dilution. Nine cloned cell lines were produced: three reacted with all GBS and six with only type 111 GBS; all were IgM as determined by reaction with specific anti-IgM heavy chain antibody (Cappell Laboratories, Cochraneville, PA). Ascites fluid was collected from animals injected intraperitoneally with hybridoma cells. Antibody preparations for these experiments were made by dialyzing ascites fluid against distilled water and resuspending the precipitate in PBS.
Animal inoculation. Sprague-Dawley albino rats from Simonson Laboratories (Gilroy, CA) were inoculated while in the first 24 h of life. After washing the right lateral chest wall with 70% ethyl alcohol, the right lung was transthoracically injected with 1 pl/g body wt of a suspension of type I11 group B streptococci containing lo9 organisms/ml using a Hamilton microliter syringe (Hamilton Co., Whittier, CA). The injection site was then held with forceps for several seconds to prevent leakage of the bacterial inoculum. If any leakage of bacterial suspension from the injection site was detected, the animal was discarded.
Either at the time of GBS inoculation or at various intervals thereafter, animals received an intraperitoneal injection of antibody. One microliter, containing 9.0 pg protein, was administered using a Hamilton microliter syringe. In other experiments 10 p1 (90.0 pg of protein) was administered. As with the GBS inoculation, following antibody administration the injection site was firmly held with forceps for several seconds to prevent leakage.
Sponge implantation. Polyvinyl sponge discs (Unipont Indus- Quantification of storage neutrophils. The total neutrophil storage pool was calculated using methods we have described previously (6) , by determining the number of polymorphonuclear leukocytes, band neutrophils, and metamyelocytes within the liver, spleen, and skeletal bone marrow. The liver and spleen were passed through sieves for nucleated cell count and differential cell counting and marrow was flushed from both femurs. The relationship of the combined femoral marrow to the total skeletal marrow has been reported previously (1 1).
Signifcance testing. Chi square analysis was used to test the null hypothesis.
RESULTS
Mortality studies. During the first 24 h of life, 169 rats received a transthoracic inoculation of lo6 type I11 group B streptococci/ g body wt. In addition, all animals received an intraperitoneal injection of 1 p1 of IgM anti-type 111 group B streptococcal antibody. In 50 animals, the antibody was administered immediately following GBS inoculation and in the others, antibody administration was delayed for 1-9 h. As is shown in Table 1 , all 50 animals which received antibody at the time of GBS inoculation survived, as did all animals which received antibody within 2 h following GBS inoculation. When antibody administration was delayed until 4 h after GBS, 92% of animals survived; when it was delayed for 5 h, 60% survived. Survival fell to 29% when the antibody was administered 6 h following GBS inoculation, and when antibody administration was delayed for 7 h or longer no animals survived.
Depletion of the neutrophil reserves following sponge implantation. In previous studies, we observed that 5-7 h following inoculation of lo6 type 111 group B streptococci/g body wt, newborn rats invariably develop profound neutropenia and depletion of the neutrophil reserves (5-7). In the present studies, we noted that 5-7 h after GBS inoculation, during the period of profound neutropenia and neutrophil reserve depletion, death could not be prevented by antibody administration. Because of this temporal relationship, we speculated that in order to provide protection from death, antibody required an intact neutrophil system, and that if the neutrophil supply was exhausted antibody administration would not prevent septic death. Therefore, in other studies, we first depleted the neutrophil supply of newborn rats by subcutaneous implantation of a sterile polyvinyl sponge (4). We then evaluated the ability of type-specific antibody to promote survival among rats whose neutrophil supply had been exhausted prior to GBS inoculation. Figure 1 shows the size of the neutrophil storage pool in newborn rats at intervals following sterile polyvinyl sponge implantation. Two hours after the sponge had been implanted, no detectable diminution in storage neutrophils had occurred, but by 6 h the quantity of reserve neutrophils had been reduced to 16 a 8% (mean a 2SD) of the initial level, indicating that 84 a 8% of the neutrophil supply had been released. At 20, 24 , and 48 h following sponge implantation, storage neutrophils remained at a similarly low level, but at 120 and 144 h, increases were observed. In order to detect bacterial contamination of sponge implants, 10 animals were sacrificed 6 h after sponge implantation and sponges were removed for bacterial culture. Bacterial growth was not detected in any of the sponges.
Mortality in neutrophil-depleted animals. When 120 control uninfected animals were subjected to no manipulation (aside from counting), 1 16 were alive 48 h later. Sponge implantation alone did not cause significant mortality as evidenced by the survival of 28 of 30 animals 48 h after being subjected to sponge Fig. 1 . Storage neutrophils (all polymorphonuclear + band neutrophils + metamyelocytes within the liver, spleen, and skeletal bone marrow) in groups of 10 or more newborn rats at various intervals following the subcutaneous placement of a sterile polyvinyl sponge disc. The range of values for storage neutrophils in neonatal rats without subcutaneous sponges is given as the shaded area. A marked diminution in storage neutrophils was observed 6 h following sponge placement ( p < 0.001).
implantation. As is shown in Table 2 , inoculation of lo6 type 111 group B streptococci/g body wt resulted in 100% mortality among 19 normal newborn rats, and all deaths occurred within 40 h of GBS inoculation. When animals with sponge-induced depletion of the neutrophil reserves were inoculated with GBS, 100% mortality was also observed; however, death occurred earlier, with 13 of 17 deaths within the first 20 h following GBS inoculation ( p < 0.001). The effect of hybridoma antibody on survival in infected normal and neutrophil-depleted rats is also shown in Table 2 . When antibody was given simultaneously with bacteria, no normal rats died, but death occurred in 10 of 11 who had pre-existing neutrophil depletion. The antibody may have delayed death, however, because as seen above, when antibody was not given to animals with neutrophil reserve depletion death generally occurred within 24 h of GBS inoculation; yet when antibody was provided, no deaths occurred within the first 24 h. Similarly, when antibody was administered 4 h after GBS inoculation, 12 of 12 normal neonatal rats survived, but no survival occurred among 12 neutrophil-depleted neonates. Again, a partial effect can be inferred from the fact that no deaths occurred within the first 24 h following inoculation. When antibody was administered 6 h after GBS inoculation, 5 of 17 normal neonates, but none of 17 neutrophil reserve-depleted neonates, survived ( p < 0.01). Furthermore, deaths occurred earlier in the neutrophil-depleted neonates: 20 h after GBS inoculation no deaths had yet occurred in the normal animals, but 12 of 17 neutrophil-depleted animals had died (p < 0.001).
In other experiments, the effect of increasing the dose of antibody in neutrophil-depleted, GBS-infected animals was tested. Fourteen neutrophil-depleted animals were transthoracically inoculated with lo6 GBS/g body wt and immediately thereafter received an intraperitoneal injection of either 9.0 or 90.0 pg antibody. Twenty others, also neutrophil depleted, received lo6 GBS/g and after 4 h, either 9.0 or 90.0 pg antibody were given. In both experiments, there was no improvement in survival among animals who received the higher dose of antibody.
DISCUSSION
Because of the frequently disappointing result when neonatal sepsis is treated with antibiotics alone, investigators have suggested that adjunctive measures, such as exchange transfusion (24, 25) , granulocyte transfusion (2, 8, 9, 15 ), or antibody administration (5, 10, 13, 2 1, 22) should be tested. While some studies suggest that each of these approaches might have merit, it is currently unclear which, if any, of these measures should be employed in various clinical situations. In order to design appropriate clinical trials in which these new putative treatments are tested, the conditions which might favor their failure or success should first be understood and experiments which simulate clinical trials should be conducted using animal models. In order to better understand the mechanism of action of type-specific hybridoma antibody, several experiments have already been performed. Our previous work (5) as well as the studies of Hams et al. (13) suggest that IgM hybridoma antibody does not kill bacteria directly, but rather acts as a potent opsonin. In addition, we have demonstrated that the antibody facilitates prompt release of neutrophils from the neutrophil storage pool into the blood, and also improves the directionality of neutrophils which have been released from the marrow reserves (5). In addition, Hathorn et al.
( 1 2) showed a more rapid and complete bacterial killing in vitro when antibody was attached to neutrophils. These studies support the concept that the neutrophil system must be functional if IgM hybridoma antibody administration is to be of value. The present studies further support this hypothesis. First, when antibody was administered early in the course of illness, while the neutrophil reserves were still intact (5,7), the mortality rate fell from 100% to zero. Second, if antibody was given to animals after their neutrophil reserves had become depleted (5-7 h following bacterial inoculation), the salutary effect of the antibody upon survival was no longer observed. Third, when the neutrophil reserves were depleted by a noninfectious stimulus, after which animals were inoculated with GBS, no protective effect from antibody was observed. Caution must be used in the interpretation of these latter studies: although sponges do deplete the neutrophil reserves, it is possible that they also produce other unrecognized changes in host defense status and that factors other than neutrophil depletion are responsible for the lack of effect of antibody in spongebearing animals. Nonetheless, because of the experimental data and theoretic considerations presented here, we suggest that antibody administration may eventually have a therapeutic role in life-threatening bacterial infection. Furthermore, we suggest that when clinical trials with antibody preparations are employed, investigators make an effort to determine the status of the neutrophil reserve of antibody recipients so that a correlation can be sought between benefit from antibody administration and presence or absence of neutrophil reserves.
